Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Grimison

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
ESMO Open|May 14, 2024
Efficacy and safety of high-dose chemotherapy as the first or subsequent salvage treatment line in patients with relapsed or refractory germ cell cancer: an international multicentric analysisC Seidel, C Schaefers, E A Connolly, et al.
Internal Medicine Journal|August 2, 2014
Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort studyB O'Carrigan, M Fournier, I N Olver, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)N Lawrence, A Martin, G Toner, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 10, 2016
Erratum to: QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30M T King, D S J Costa, N K Aaronson, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 22, 2016
QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30M T King, D S J Costa, N K Aaronson, et al.
Cancer Chemotherapy and Pharmacology|June 24, 2016
TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancerD Ferraro, D Goldstein, R L O'Connell, et al.
ESMO Open|June 19, 2022
Systemic treatment of advanced clear cell sarcoma: results from a retrospective international series from the World Sarcoma NetworkA Smrke, A M Frezza, C Giani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 18, 2020
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trialP Grimison, A Mersiades, A Kirby, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
ESMO Open|May 14, 2024
Efficacy and safety of high-dose chemotherapy as the first or subsequent salvage treatment line in patients with relapsed or refractory germ cell cancer: an international multicentric analysisC Seidel, C Schaefers, E A Connolly, et al.
Internal Medicine Journal|August 2, 2014
Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort studyB O'Carrigan, M Fournier, I N Olver, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)N Lawrence, A Martin, G Toner, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 10, 2016
Erratum to: QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30M T King, D S J Costa, N K Aaronson, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 22, 2016
QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30M T King, D S J Costa, N K Aaronson, et al.
Cancer Chemotherapy and Pharmacology|June 24, 2016
TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancerD Ferraro, D Goldstein, R L O'Connell, et al.
ESMO Open|June 19, 2022
Systemic treatment of advanced clear cell sarcoma: results from a retrospective international series from the World Sarcoma NetworkA Smrke, A M Frezza, C Giani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 18, 2020
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trialP Grimison, A Mersiades, A Kirby, et al.
Pageof 2